NCT03384615

Brief Summary

Prolonged grief disorder (PGD) is a novel diagnostic entity proposed to describe a psychiatric disorder that occurs after the loss of a loved one. The disorder is to be implemented in The International Classification of Diseases 11th Revision (ICD-11), scheduled for release in 2018. Failure to recognize and treat PGD may have negative effects on health, functional capacity and quality of life. However, very little is known about the characteristics and treatment of PGD in adult Danish populations although such knowledge is much needed before introducing the disorder in Danish health services. The present study aims to develop, test and disseminate a group-based treatment manual for PGD in bereaved partners and their adult children. People with high levels of symptoms will be recruited from a large-scale survey study examining frequency, predictors and prognosis of PGD symptoms (NCT03049007). Participants will be randomized to group-based compassion-focused therapy (CFT) for grief or a waitlist control group. Treatment effects will be estimated with prolonged grief symptoms as the primary outcome. Secondary outcomes include depressive symptoms, posttraumatic stress symptoms, symptoms of anxiety, and quality-of-life. The investigators expect that CFT will yield statistically significant effects on prolonged grief symptom compared with the waitlist control group. If CFT is shown to be efficacious in reducing prolonged grief symptoms, the investigators will conduct moderation and mediation analyses with the aim of identifying what works, for whom. Finally, the investigators will perform cost-effectiveness analyses by linking the data with healthcare utilization data from the Danish National registries.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
82

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 14, 2017

Completed
13 days until next milestone

First Posted

Study publicly available on registry

December 27, 2017

Completed
7 days until next milestone

Study Start

First participant enrolled

January 3, 2018

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2020

Completed
Last Updated

November 5, 2020

Status Verified

July 1, 2019

Enrollment Period

2 years

First QC Date

December 14, 2017

Last Update Submit

November 4, 2020

Conditions

Outcome Measures

Primary Outcomes (2)

  • Prolonged grief symptoms

    Prolonged grief (PG-13; Prigerson et al., 2009)

    From baseline (T1) to immediately after the intervention (8 weeks) (T2)

  • Prolonged grief symptoms

    Prolonged grief (PG-13; Prigerson et al., 2009)

    From baseline (T1) to 6 months after the intervention (T4)

Secondary Outcomes (6)

  • Prolonged Grief Disorder (PGD) (diagnostic criteria)

    From baseline (T1) to 6 months after the intervention (T4)

  • Anxiety symptoms

    From baseline (T1) to 6 months after the intervention (T4)

  • Depression symptoms

    From baseline (T1) to 6 months after the intervention (T4)

  • Posttraumatic stress symptoms

    From baseline (T1) to 6 months after the intervention (T4)

  • Utility measure

    From baseline (T1) to 6 months after the intervention (T4)

  • +1 more secondary outcomes

Other Outcomes (11)

  • Mediator: Self-criticism

    Baseline (T1), session-by-session measures (SES1-8), to immediately after the intervention (8 weeks) (T2)

  • Mediator: Fear of compassion

    Baseline (T1), session-by-session measures (SES1-8), to immediately after the intervention (8 weeks) (T2)

  • Mediator: Experiential avoidance

    Baseline (T1), session-by-session measures (SES1-8), to immediately after the intervention (8 weeks) (T2)

  • +8 more other outcomes

Study Arms (2)

Compassion-focused therapy

EXPERIMENTAL
Behavioral: Compassion-Focused Therapy

Waitlist control group

NO INTERVENTION

Interventions

CFT for PGD symptoms in the present project is inspired by two well-established CFT treatment manuals. The first is used for treatment of PTSD (Lee \& James, 2011) and the other for treatment of anger (Kolt, 2011). The manual for CFT for PGD adopts both structure and techniques from these into an 8-week, group-based program with weekly 2 1/4-hour sessions. Each session contains elements of psychoeducation on uncomplicated and prolonged grief reactions, identifying unhelpful strategies for self-protection and facilitating use of more helpful strategies, and training an open and compassionate management of grief-related distress through CFT exercises. Between the sessions the participant will train the exercises introduced at the previous session.

Also known as: CFT for PGD symptoms
Compassion-focused therapy

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Residence in the Central Region of Denmark
  • Status of partner or child to the deceased
  • A min. score of 25 on the PG-13 at 11 months after the loss

You may not qualify if:

  • Insufficient ability to understand Danish
  • Serious psychiatric disease, e.g., schizophrenia, bipolar disease
  • Acute suicidal ideation
  • Serious cognitive impairment, e.g., Alzheimer's disease
  • Active treatment for serious disease, e.g., chemotherapy for cancer

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Unit for Bereavement Research, Dept. of Psychology, Aarhus University

Aarhus C, 8000, Denmark

Location

Related Links

Study Officials

  • Maja O'Connor, MSc., PhD

    University of Aarhus

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Block randomization in REDcap (copyright by Vanderbuilt University, USA) conducted by external biostatistician
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 14, 2017

First Posted

December 27, 2017

Study Start

January 3, 2018

Primary Completion

January 1, 2020

Study Completion

January 1, 2020

Last Updated

November 5, 2020

Record last verified: 2019-07

Locations